Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal preparation containing exenatide

A pharmaceutical preparation, exenatide technology, applied in the field of exenatide stable pharmaceutical preparations, can solve the problems of exenatide stability cannot be guaranteed, affect the curative effect, and dosage changes

Inactive Publication Date: 2010-03-17
HANGZHOU JIUYUAN GENE ENG
View PDF2 Cites 38 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, if the stability of exenatide during storage cannot be guaranteed, it will lead to changes in the dosage and affect the efficacy

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Medicinal preparation containing exenatide
  • Medicinal preparation containing exenatide
  • Medicinal preparation containing exenatide

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0069] Example 1: Screening of preservatives

[0070] In order to study the stability of exenatide under the condition of adding different preservatives, the following experiment was carried out, the method is as follows: first prepare different preservative solutions, each solution contains 3% methionine and 20mM pH 4.5 Disodium hydrogen phosphate-citric acid buffer solution, then weigh exenatide, add it to different preservative solutions and dissolve it into an exenatide preparation solution of about 250 μg / ml, and then use NaOH or HCl to adjust the pH to 4.5. After the preparation, put it into a 25°C incubator for accelerated testing. Samples were taken every 2 weeks and tested by HPLC to observe the degradation of the samples. The specific results are shown in the table below.

[0071] Byetta prescription: Exenatide 250μg / ml + m-cresol 2.2mg / ml + 4% mannitol + 30mM acetate buffer

[0072] Table 6: Addition of different preservatives

[0073]

[0074] Table 7: Conten...

example 2

[0077] Example 2: Screening of different concentrations of sodium benzoate

[0078] First prepare sodium benzoate solutions containing different concentrations, each solution contains 3% methionine and 20mM pH 4.5 disodium hydrogen phosphate-citric acid buffer, then weigh exenatide, add it to different Dissolve in preservative solution to form about 250 μg / ml exenatide preparation solution, then adjust pH to 4.5 with NaOH or HCl. After the preparation, put it into a 25°C incubator for accelerated testing. Samples were taken every 2 weeks and tested by HPLC to observe the degradation of the samples. The specific results are shown in the table below.

[0079] Table 8: Periodic reverse-phase detection of the content of related substances

[0080]

[0081] Can get from above-mentioned result: the sodium benzoate of 0.005%-5% (especially 0.2%-2.0%) has antiseptic effect preferably, but considers that preservative generally has certain toxic effect to human body, therefore adopt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to View More

Abstract

The invention provides a medicinal preparation containing exenatide suitable for multi-administration, which contains exenatide, buffer solution, pharmaceutically acceptable accessory and preservative, wherein the buffer solution can keep the pH value of the preparation in an aqueous solution state at 3.0 to 7.0; the accessory may be one or combination of glucose, sucrose, methionine, mannitol or glycine; and the preservative is selected from benzoic acid, sodium benzoate, potassium sorbate or acetone chloroform. The medicinal preparation has the advantages that the stability of physicochemical and biological activities of the exenatide is enhanced by adding a few components capable of being accepted by the human body, and then a preparation suitable for clinical use, particularly injection use is prepared.

Description

field of invention [0001] The invention relates to a stable pharmaceutical preparation of exenatide, which can be used for the treatment of diabetic patients. technical background [0002] Exenatide (exenatide or exendin-4) was first isolated from the saliva secretion of giant monster lizard (Heloderm suspectum) (Eng, J. et al., J.Biol.Chem., 265:20259-62, 1990; Eng, J. et al., J.Biol.Chem., 267:7402-05, 1992), this is a 39-amino acid polypeptide whose amino acid sequence is similar to that of glucagon-like peptide-1 (GLP- 1) It has about 53% homology (Goke et al., J. Biol. Chem., 268:19650-55, 1993), and its amino acid sequence structure is as follows: [0003] His-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Leu-Ser-Lys-Gln-Met-Glu-Glu-Glu-Ala-Val-Arg-Leu-Phe-Ile-Glu-Trp- Leu-Lys-Asn-Gly-Gly-Pro-Ser-Ser-GIy-Ala-Pro-Pro-Pro-Ser [0004] Pharmacological studies have found that exenatide has a similar effect to GLP-1, that is, it can stimulate pancreatic β cells to secrete insulin. Ex...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/17A61K9/08A61K9/19A61P3/10
Inventor 马国昌周哲程睿方井晋王同映
Owner HANGZHOU JIUYUAN GENE ENG
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com